PTX 4.65% 4.1¢ prescient therapeutics limited

Very true. But remember PTX100 expansion trial is positioning...

  1. 4,351 Posts.
    lightbulb Created with Sketch. 2033
    Very true.

    But remember PTX100 expansion trial is positioning for a fast track approval. So a phase 2b trial leading to FDA approval. Well achievable for a company like PTX.

    So potential future revenue from drug to market, OmniCar and cool cell tech.

    Think of what market cap the above would command?

    Our market cap now doesnt fully cover the pipeline as it is, so we have lots of room for the share to still move. The support seen at 18 to 18.5c is bullish.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.1¢
Change
-0.002(4.65%)
Mkt cap ! $33.01M
Open High Low Value Volume
4.3¢ 4.3¢ 4.1¢ $19.06K 451.5K

Buyers (Bids)

No. Vol. Price($)
6 799173 4.1¢
 

Sellers (Offers)

Price($) Vol. No.
4.3¢ 12500 1
View Market Depth
Last trade - 16.10pm 29/08/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.